Regadenoson 55150-0443-01

Package NDC

55150-0443-01

Manufacturer: Eugia Us Llc
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: October 26, 2022
Listing Expires: December 31, 2026
Application: ANDA216437

Need to source Regadenoson? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Regadenoson	.08 mg/mL

Drug Class

Adenosine Receptor Agonist [EPC]Adenosine Receptor Agonists [MoA]Pharmacologic Cardiac Stress Test Agent [EPC]

Selected Package

55150-0443-01Selected

1 SYRINGE in 1 CARTON (55150-443-01) / 5 mL in 1 SYRINGE